Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07262255 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

WATCHMAN FLX Pro European Registry

StatusActive, Not Recruiting
PhaseNot specified
Started2025-12-17
View on ClinicalTrials.gov ↗

Amendment history

2026-09-01
Study Status, Contacts/Locations v13
Enrollment closed, study ongoing
Final enrollment: 189 participants (planned 1000)
Study sites19→20
2026-08-12
Study Status, Contacts/Locations v12
Study sites18→19
2026-08-04
Study Status v11
Re-verified, no change to tracked fields
2026-07-31
Study Status, Contacts/Locations v10
Trial sites expanded: 14 → 18 locations
2026-06-23
Study Status, Contacts/Locations v9
Study sites13→14
2026-05-21
Study Status, Study Design, Arms and Interventions, Eligibility, Contacts/Locations v8
Phase changed: not applicable → not specified
Study sites11→13
2026-05-07
Study Status, Contacts/Locations v7
Trial sites expanded: 7 → 11 locations
2026-04-08
Study Status, Contacts/Locations v6
Study sites5→7
2026-03-21
Study Status, Contacts/Locations v5
Study sites3→5
2026-02-28
Study Status, Contacts/Locations v4
Study sites2→3
2026-01-16
Study Status, Contacts/Locations v3
Study sites1→2
2026-01-12
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-12→confirmed 2025-12-17
Study sites0→1
2025-12-10
Study Status v1
Re-verified, no change to tracked fields
2025-11-21
Original filing
The WATCHMAN FLX Pro European registry is intended to gather real world clinical data for patients undergoing left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro device. In a subregistry with approximately 300 patients, it is intended to use the VersaCross Connect™ LAAC Access Solution.
Trial Details
NCT Number NCT07262255
Lead Sponsor Boston Scientific Corporation
Conditions Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure
Enrollment 189 participants
Start Date 2025-12-17
Primary Completion 2027-08 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-30